Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

Hydergine Found To Be Ineffective for Alzheimer’s Disease Treatment

OPEN MINDS The Behavioral Health & Social Service Industry Analyst Industry News Hydergine, the only approved medication, in the United States for the treatment of Alzheimer’s disease may not be effective, according to a study that was published in the August 16, 1990 issue of the New England Journal of Medicine and reviewed in the September 21, 1990 issue of Psychiatric News. The study was conducted by a team of researchers led by psychiatrist Troy L. Thompson II, M.D. of Jefferson Medical College in Philadelphia. After conducting a double-blind, placebo-controlled trial of 24 weeks with eight . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.